SARS-CoV-2 Surface GP_1 B7 (HLA-B*07:02)

SARS-CoV-2 Surface GP_1 B7 (HLA-B*07:02)
€80.00 *

Prices plus VAT plus shipping costs

Delivery time 2-3 days
sterile and endotoxin free Delivery Format:
The product is supplied freeze dried as trifluoracetate salt

Amount in mg:

5 mg

  • EP14617_1
Coronavirus disease 2019, known as COVID-19, is an infectious desease caused by severe acute... more
Product information "SARS-CoV-2 Surface GP_1 B7 (HLA-B*07:02)"
Coronavirus disease 2019, known as COVID-19, is an infectious desease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), a virus closely related to the SARS virus. The virus structure consists of RNA, membrane glycoprotein (M), hemagglutinin-esterease dimer (HE), envelope protein (E), nucleocapsid protein (N), spike or surface glycoprotein (S) and others. The surface glycoprotein is present on the coronavirus envelope and it binds to the ACE2 protein on the host cell surface. SARS-CoV-2 Surface GP_1 B7 (HLA-B*07:02) is a linear peptidic epitope studied as part of surface glycoprotein from severe acute respiratory syndrome-related coronavirus.

 
Sequence:SPRRARSVA
Delivery: 2-3 days
C-Terminus:OH
N-Terminus:H
Purity:95%
Amount:1 mg
Counter Ion:TFA
Species:SARS-CoV-2
Allele:HLA-B*07:02
Application :Flow Cytometry
Indication :Coronavirus(COVID-19)
Viewed